There were dynamic and sometimes forceful pursuits that were conducted in the past. However, these researches often failed to determine what they called as the signals of degradation of tumors. It was because of this that another team of researches were motivated to make another study. This research team was affiliated with the German Cancer Research Center situated in Heidelberg in Germany. These people resolved to do a reverse approach in their undertaking. They did not look for the “hunger signals” in the tumor. As an alternative, they made examinations on the signaling chain, this time, on the other end. A group mice’ liver cells were employed in the study. Needless to say, these mice were, of course, should have been cancer victims. The researchers were able to find out about a molecular marker. This marker had the power over the metabolic procedures as well as the responses of the inflammation.

        Furthermore, it was noticed that in the later cancer phases, most especially in cancers of the lung and the pancreas, patients most often experience some form of suffering because of cancer cachexia. This is also known as the wasting syndrome. Patients who are affected were described to shed so much weight that they turn really thin. Consecutively, these people become very weak. This could result to having an organ failure. The reduction of the body fat is evident. The buildup of such in the liver could pave the way to having fatty liver. As what has been mentioned already in the previous statements, this procedure appeared to be a result by indications which come from the tumor itself. The tumor could aim at metabolic procedures inside the body heading for degradation. This could result to a situation of unceasing inflammation. Unfortunately, though there were already exhaustive efforts were pursued, the identification of these indications and signals still failed.

        Moreover, Stephan Herzig and his colleagues decided to concentrate on the signaling chain’s other end. They investigated on the cells of the liver of tumor-bearing mice which illustrated some indications of acute cancer cachexia. Specifically, they looked for RIP140. This is a molecule that had been recognized by Herzig beforehand. Herzig knew that this molecule was a regulator which held back the collapse of fats in healthy mice’ livers. Understandably, an elevated action of RIP140 in mice that had cancers was apparent. There were also indications of fatty liver.

        Also, the presence of immune cells that are active and elevated were also apparent. This was regarded to be another trait of tumor wasting. An inflammatory reaction in the organs which could ultimately be a factor to an interference of metabolism and energy loss in concerned patients is also perceptible. The original article cited several information on the findings of this study. However, the outcomes of this research also could be seen in Blood. Herzig conveyed that another tiny connection into the lengthy unidentified signaling chain from one tumor to cachexia had been discovered. But then, he also added that they would still look for RIP140. This is necessary in order to be able to continue searching and reaching the tumor. The researchers still hope to locate the “hunger signal” of tumors.